glp 1 agonist tirzepatide is a first-in-class dual targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management., By acting on multiple See if you qualify. New studies continue to show

This unique combination makes Retatrutide one of the most promising weight management and metabolic health treatments to date

The other important aim of modern anti-diabetic therapy is to reduce mortality risk and long-term complications of T2DM, such as cardiovascular, renal and neurological damage

Semaglutide (Ozempic) is available in (weekly) injectable form for T2DM

doi: 10.1038/sj.ijo.0802206 65

Semaglutide with pyridoxine versus tirzepatide with B6 Tirzepatide (the active ingredient in brand-name Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss efficacy than semaglutide in head-to-head trials

No claim of ownership is made by this publication